CCL2 and colonic neoplasm: CCL2 induces MDSC accumulation in evolving colonic tumors and enhances polymorphonuclear-MDSC immunosuppressive features, resulting in T lymphocyte suppression by polymorphonuclear-MDSCs in a STAT3-mediated manner [56].